Az Innovative Medicines Initiative 2010-re tervezett tudományos prioritásai, amelyek a későbbiekben megjelenő 3. felhívás témaköreinek alapját képezik.
Summary of Scientific Priorities (Priority-Title-Pillar-Scientific Area)
A.) Assessment of drug induced toxicity in relevant organs – surrogates for early drug failure / Safety-General Safety
B.) Immunological Safety of Biopharmaceuticals / Safety-Immunology
C.) Assessment inflammatory disease / Efficacy- Inflammatory Diseases
D.) Improve the scientific and pre-clinical infrastructure for Tuberculosis medicine / Efficacy – Infectious Diseases
E.) Enhancing translation in neurological disease / Efficacy – CNS
F.) Development of personalized medicine approaches in diabetes / Efficacy – Metabolic Diseases
G.) Fostering a broader understanding of pharmaceutical R&D in the broader public / Education & Training
Bővebb információ: itt
